Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Secreted frizzled-related protein 1 regulates adipose tissue expansion and is dysregulated in severe obesity

Abstract

Aim:

The Wnt/β-catenin signaling network offers potential targets to diagnose and uncouple obesity from its metabolic complications. In this study, we investigate the role of the Wnt antagonist, secreted frizzled-related protein 1 (SFRP1), in promoting adipogenesis in vitro and adipose tissue expansion in vivo.

Methods:

We use a combination of human and murine, in vivo and in vitro models of adipogenesis, adipose tissue expansion and obesity-related metabolic syndrome to profile the involvement of SFRP1.

Results:

SFRP1 is expressed in both murine and human mature adipocytes. The expression of SFRP1 is induced during in vitro adipogenesis, and SFRP1 is preferentially expressed in mature adipocytes in human adipose tissue. Constitutive ectopic expression of SFRP1 is proadipogenic and inhibits the Wnt/β-catenin signaling pathway. In vivo endogenous levels of adipose SFRP1 are regulated in line with proadipogenic states. However, in longitudinal studies of high-fat-diet-fed mice, we observed a dynamic temporal but biphasic regulation of endogenous SFRP1. In agreement with this profile, we observed that SFRP1 expression in human tissues peaks in patients with mild obesity and gradually falls in morbidly obese subjects.

Conclusions:

Our results suggest that SFRP1 is an endogenous modulator of Wnt/β-catenin signaling and participates in the paracrine regulation of human adipogenesis. The reduced adipose expression of SFRP1 in morbid obesity and its knock-on effect to prevent further adipose tissue expansion may contribute to the development of metabolic complications in these individuals.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Despres JP, Lemieux I . Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881–887.

    Article  CAS  Google Scholar 

  2. Sethi JK, Vidal-Puig AJ . Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res 2007; 48: 1253–1262.

    Article  CAS  Google Scholar 

  3. Virtue S, Vidal-Puig A . It's not how fat you are, it's what you do with it that counts. PLoS Biol 2008; 6: e237.

    Article  Google Scholar 

  4. Tan CY, Vidal-Puig A . Adipose tissue expandability: the metabolic problems of obesity may arise from the inability to become more obese. Biochem Soc Trans 2008; 36: 935–940.

    Article  CAS  Google Scholar 

  5. Guilherme A, Virbasius JV, Puri V, Czech MP . Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008; 9: 367–377.

    Article  CAS  Google Scholar 

  6. Wodarz A, Nusse R . Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 1998; 14: 59–88.

    Article  CAS  Google Scholar 

  7. Logan CY, Nusse R . The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004; 20: 781–810.

    Article  CAS  Google Scholar 

  8. Prestwich TC, Macdougald OA . Wnt/beta-catenin signaling in adipogenesis and metabolism. Curr Opin Cell Biol 2007; 19: 612–617.

    Article  CAS  Google Scholar 

  9. Christodoulides C, Lagathu C, Sethi JK, Vidal-Puig A . Adipogenesis and WNT signalling. Trends Endocrinol Metab 2009; 20: 16–24.

    Article  CAS  Google Scholar 

  10. Kennell JA, MacDougald OA . Wnt signaling inhibits adipogenesis through beta-catenin-dependent and -independent mechanisms. J Biol Chem 2005; 280: 24004–24010.

    Article  CAS  Google Scholar 

  11. Cawthorn WP, Heyd F, Hegyi K, Sethi JK . Tumour necrosis factor-alpha inhibits adipogenesis via a beta-catenin/TCF4(TCF7L2)-dependent pathway. Cell Death Differ 2007; 14: 1361–1373.

    Article  CAS  Google Scholar 

  12. Christodoulides C, Laudes M, Cawthorn WP, Schinner S, Soos M, O’Rahilly S et al. The Wnt antagonist Dickkopf-1 and its receptors are coordinately regulated during early human adipogenesis. J Cell Sci 2006; 119: 2613–2620.

    Article  CAS  Google Scholar 

  13. Farmer SR . Transcriptional control of adipocyte formation. Cell Metab 2006; 4: 263–273.

    Article  CAS  Google Scholar 

  14. Rosen ED, MacDougald OA . Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 2006; 7: 885–896.

    Article  CAS  Google Scholar 

  15. Bennett CN, Ross SE, Longo KA, Bajnok L, Hemati N, Johnson KW et al. Regulation of Wnt signaling during adipogenesis. J Biol Chem 2002; 277: 30998–31004.

    Article  CAS  Google Scholar 

  16. Jones SE, Jomary C . Secreted frizzled-related proteins: searching for relationships and patterns. Bioessays 2002; 24: 811–820.

    Article  CAS  Google Scholar 

  17. Kawano Y, Kypta R . Secreted antagonists of the Wnt signalling pathway. J Cell Sci 2003; 116: 2627–2634.

    Article  CAS  Google Scholar 

  18. Dennis S, Aikawa M, Szeto W, d’Amore PA, Papkoff J . A secreted frizzled related protein, FrzA, selectively associates with Wnt-1 protein and regulates wnt-1 signaling. J Cell Sci 1999; 112 (Pt 21): 3815–3820.

    CAS  PubMed  Google Scholar 

  19. Galli LM, Barnes T, Cheng T, Acosta L, Anglade A, Willert K et al. Differential inhibition of Wnt-3a by Sfrp-1, Sfrp-2, and Sfrp-3. Dev Dyn 2006; 235: 681–690.

    Article  CAS  Google Scholar 

  20. Bodine PV, Zhao W, Kharode YP, Bex FJ, Lambert AJ, Goad MB et al. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol Endocrinol 2004; 18: 1222–1237.

    Article  CAS  Google Scholar 

  21. Ortega FJ, Mayas D, Moreno-Navarrete JM, Catalan V, Gomez-Ambrosi J, Esteve E et al. The gene expression of the main lipogenic enzymes is downregulated in visceral adipose tissue of obese subjects. Obesity (Silver Spring) 2009; 18: 13–20.

    Article  Google Scholar 

  22. Pietilainen KH, Naukkarinen J, Rissanen A, Saharinen J, Ellonen P, Keranen H et al. Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity. PLoS Med 2008; 5: e51.

    Article  Google Scholar 

  23. Lagathu C, Christodoulides C, Virtue S, Cawthorn WP, Franzin C, Kimber WA et al. Dact1, a nutritionally regulated preadipocyte gene, controls adipogenesis by coordinating the Wnt/beta-catenin signaling network. Diabetes 2009; 58: 609–619.

    Article  CAS  Google Scholar 

  24. Medina-Gomez G, Virtue S, Lelliott C, Boiani R, Campbell M, Christodoulides C et al. The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-gamma2 isoform. Diabetes 2005; 54: 1706–1716.

    Article  CAS  Google Scholar 

  25. Laudes M, Christodoulides C, Sewter C, Rochford JJ, Considine RV, Sethi JK et al. Role of the POZ zinc finger transcription factor FBI-1 in human and murine adipogenesis. J Biol Chem 2004; 279: 11711–11718.

    Article  CAS  Google Scholar 

  26. Isakson P, Hammarstedt A, Gustafson B, Smith U . Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation. Diabetes 2009; 58: 1550–1557.

    Article  CAS  Google Scholar 

  27. Yang X, Jansson PA, Nagaev I, Jack MM, Carvalho E, Sunnerhagen KS et al. Evidence of impaired adipogenesis in insulin resistance. Biochem Biophys Res Commun 2004; 317: 1045–1051.

    Article  CAS  Google Scholar 

  28. Permana PA, Nair S, Lee YH, Luczy-Bachman G, Vozarova De Courten B, Tataranni PA . Subcutaneous abdominal preadipocyte differentiation in vitro inversely correlates with central obesity. Am J Physiol Endocrinol Metab 2004; 286: E958–E962.

    Article  CAS  Google Scholar 

  29. Tchoukalova Y, Koutsari C, Jensen M . Committed subcutaneous preadipocytes are reduced in human obesity. Diabetologia 2007; 50: 151–157.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank the Addenbrooke's hospital surgeons for performing the adipose tissue biopsies. This research is funded by the Biotechnology and Biological Science Research Council (BBSRC), the Medical Research Council (MRC) and the European Union Sixth Framework Programme on Hepatic and Adipose tissue functions in the metabolic syndrome (EU-FP6 HEPADIP) (AV-P and JKS). We also acknowledge the support received from ALFEDIAM and Marie Curie Postdoctoral fellowship (CL), MRC Doctoral Studentships (CC and SV), MRC Career Establishment Award (AV-P) and BBSRC David Phillips Fellowship (JKS).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to J K Sethi or A Vidal-Puig.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on International Journal of Obesity website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lagathu, C., Christodoulides, C., Tan, C. et al. Secreted frizzled-related protein 1 regulates adipose tissue expansion and is dysregulated in severe obesity. Int J Obes 34, 1695–1705 (2010). https://doi.org/10.1038/ijo.2010.107

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2010.107

Keywords

This article is cited by

Search

Quick links